Eurand N.V. announced that the FDA has granted orphan drug designation for EUR-1073 (beclomethasone diproprionate) in pediatric patients.
The INTERPHEX Conference will feature three days of comprehensive educational opportunities to reflect the trends and challenges facing pharmaceutical and biopharmaceutical professionals today.
A new interchangeable reactor tray is now available for the Uniqsis FlowSyn Continuous Flow Reactor.
MIT researchers have demonstrated that a gel composed of small, woven protein fragments can successfully carry and release proteins of different sizes, potentially enabling delivery of drugs such as insulin and trastuzumab (Herceptin).
Millipore Corporation introduced the Milli-Q Reference water purification system at Pittcon 2009.
Synosia Therapeutics announced it has entered into a second agreement with Roche, adding a further promising molecule to Synosia’s clinical pipeline.
PerkinElmer, Inc. announced the inauguration of a new Center of Excellence (COE) in Singapore.
A study involving two common drugs used to treat early-stage Parkinson's disease shows that, while the drugs each have advantages and disadvantages, the overall impact tends to even out over a long period of treatment.
Seahorse Bioscience announced the acquisition of BioProcessors Corp.
Evotec AG and Roche announced that they have entered into an agreement for Phase 2 clinical development of EVT 101 in patients with treatment-resistant depression.
HaydonKerk Motion Solutions showcased its MotoDrive PDE linear actuator and MotoRGS motorized linear slide assembly in Booth # 2473 at Pittcon 2009.
Novozymes Biopharma announced a signed license agreement with GE Healthcare Life Sciences.
Tecan and GE Healthcare are working together to bring increased quality and efficiency to process development.
Sono-Tek Corporation announces that it will showcase the SonoDry 1000 spray drying system in booth 983 at INTERPHEX 2009.